AMEH, NASDAQ #Positive Financials #Trending News Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2022 Results February 23, 2023 16:35 EST Company to Host Conference Call on Friday, Feb. 24, 2023, at 5:30 a.m. PT/8:30 a.m. ET ALHAMBRA, Calif., Feb. 23, 2023 /PRNewswire/ — Apollo Medical Holdings, Inc. (“ApolloMed,” and together with its subsidiaries and affiliated entities, the “Company”) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling No Comments
NYSE, SEM #Dividends #Positive Financials #Trending News Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2022 and Cash Dividend February 23, 2023 16:30 EST MECHANICSBURG, Pa., Feb. 23, 2023 /PRNewswire/ — Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2022 and the declaration of a cash dividend. For the fourth quarter ended December 31, 2022, revenue increased 1.4% to No Comments
NASDAQ, NKTR #New Clinical Trial Data #Phase 2 #Trending News Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus February 23, 2023 16:30 EST Improvement in SLEDAI-2K score observed as compared to placebo, although study did not meet primary endpoint Clinically meaningful improvements observed as compared to placebo across secondary endpoints including BICLA and LLDAS at the mid-dose level in the study Nektar and Lilly are discussing next steps for trials planned in No Comments
GBIO, NASDAQ #Financial Data #Liver #Trending News Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results February 23, 2023 16:28 EST — Company expects to announce data for Factor VIII expression in non-human primates in 2023 — Strong cash balance of $279.1M provides expected runway into 2025 CAMBRIDGE, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with No Comments
NYSE, SWN #Financial Data #Published Forecast #Share Repurchase #Trending News Southwestern Energy Announces Fourth Quarter and Full Year 2022 Results; Provides 2023 Guidance February 23, 2023 16:21 EST SPRING, Texas–(BUSINESS WIRE)–Southwestern Energy Company (NYSE: SWN) (the “Company” or “Southwestern Energy”) today announced financial and operating results for the fourth quarter and full-year 2022 and provided 2023 guidance. “In 2022, the Company delivered results that both strengthened its financial position and demonstrated the tangible benefits of its expanded No Comments
NGL, NYSE #Notes Redemption #Trending News NGL Energy Partners LP Announces Redemption of 7.5% Senior Notes due 2023 February 23, 2023 16:20 EST TULSA, Okla.–(BUSINESS WIRE)–NGL Energy Partners LP (NYSE:NGL) (“NGL,” “our,” “we,” or the “Partnership”) today announced that it intends to call for redemption, all $203,400,000 aggregate outstanding principal amount of its 7.5% Senior Notes due 2023 (the “Notes”). On March 31, 2023 (the “Redemption Date”), registered holders of such Notes No Comments
MRIN, NASDAQ #Financial Data #Trending News Marin Software Announces Fourth Quarter and Full Year 2022 Financial Results February 23, 2023 16:20 EST SAN FRANCISCO–(BUSINESS WIRE)–Marin Software Incorporated (NASDAQ: MRIN), a leading provider of digital marketing software for performance-driven advertisers and agencies, today announced financial results for the fourth quarter and full year ended December 31, 2022. “Every advertiser faces two fundamental questions: how much should I be spending and where should No Comments
NASDAQ, SERA #Investor Conference #Trending News SERA PROGNOSTICS TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES February 23, 2023 16:20 EST SALT LAKE CITY, Feb. 23, 2023 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the upcoming Cowen Health Care Conference March 6-8, 2023 No Comments
AMEX, SNMP #Approval #Trending News NYSE American Approves Evolve’s Plan to Regain Compliance February 23, 2023 16:20 EST HOUSTON, Feb. 23, 2023 (GLOBE NEWSWIRE) — Evolve Transition Infrastructure LP (NYSE American: SNMP) (“Evolve” or the “Partnership”) today announced that on February 21, 2023, the NYSE American LLC (“NYSE American” or the “Exchange”) notified the Partnership that it has accepted the Partnership’s plan to regain compliance with the No Comments
ABVC, OTC #Funding #Trending News ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials February 23, 2023 16:16 EST FREMONT, CA, Feb. 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it has closed a funding agreement for gross proceeds of $3.175 million (the “Investment”) with Lind Global Fund No Comments
Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock 02/23/2023
Columbia Banking System Set to Join S&P MidCap 400; Verra Mobility to Join S&P SmallCap 600 02/23/2023